Financials

  • Market Capitalization 12.24 B
  • Employee 915
  • Founded 2011
  • CEO Paul A. Friedman
  • Website www.madrigalpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000QS6NV8
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-45.32
Fiyat/satışlar oranı
13.63

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
711
JAZZ
Jazz Pharmaceuticals plc - Ordinary Shares
236.97 USD-2.81%-2.83%+2.78%+69.26%14.87 B USD
731
EXEL
Exelixis, Inc. - Common Stock
56.04 USD-0.81%-0.21%+5.14%+43.55%14.09 B USD
823
SMMT
Summit Therapeutics Inc. - Common Stock
15.30 USD+0.33%-4.20%+5.96%-22.96%11.88 B USD
828
AXSM
Axsome Therapeutics, Inc. - Common Stock
228.28 USD-2.36%-5.79%-10.25%+75.33%11.75 B USD

Haberler